Operating

Other Noncash Income (Expense)

Merck & Co. Other Noncash Income (Expense) increased by 83.1% to -$20.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 81.7%, from -$109.00M to -$20.00M. Over 3 years (FY 2021 to FY 2025), Other Noncash Income (Expense) shows an upward trend with a -11.3% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 4, 2026

How to read this metric

Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.

Detailed definition

This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...

Peer comparison

Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.

Metric ID: operating_other_noncash_income_expense

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$92.00M-$171.00M-$306.00M-$143.00M-$656.00M-$370.00M-$132.00M$197.00M-$202.00M$86.00M-$436.00M-$83.00M-$91.00M-$437.00M-$109.00M-$335.00M$0.00-$118.00M-$20.00M
QoQ Change-85.9%-78.9%+53.3%-358.7%+43.6%+64.3%+249.2%-202.5%+142.6%-607.0%+81.0%-9.6%-380.2%+75.1%-207.3%+100.0%+83.1%
YoY Change-613.0%-116.4%+56.9%+237.8%+69.2%+123.2%-230.3%-142.1%+55.0%-608.1%-31.3%-268.1%+100.0%+81.7%
Range-$656.00M$197.00M
CAGR-28.8%
Avg YoY Growth-91.8%
Median YoY Growth+11.8%

Frequently Asked Questions

What is Merck & Co.'s other noncash income (expense)?
Merck & Co. (MRK) reported other noncash income (expense) of -$20.00M in Q1 2026.
How has Merck & Co.'s other noncash income (expense) changed year-over-year?
Merck & Co.'s other noncash income (expense) increased by 81.7% year-over-year, from -$109.00M to -$20.00M.
What is the long-term trend for Merck & Co.'s other noncash income (expense)?
Over 3 years (2021 to 2025), Merck & Co.'s other noncash income (expense) has grown at a -11.3% compound annual growth rate (CAGR), from -$805.00M to -$562.00M.
What does other noncash income (expense) mean?
Miscellaneous non-cash income or expenses that impact net income but not cash flow.